WWOX suppresses prostate cancer cell progression through cyclin D1-mediated cell cycle arrest in the G1 phase

Cell Cycle

Volumn 14, Issue 3, 2015, Pages 408-416

  Lin, Jen Tai ^a,b   Li, Hao Yi ^a   Chang, Nan Shan ^a   Lin, Cheng Han ^a   Chen, Yu Chia ^b   Lu, Pei Jung ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Cell cycle; Cyclin D1; Prostate cancer; Tumor suppressor; WWOX

Indexed keywords

CYCLIN D1; GREEN FLUORESCENT PROTEIN; NOCODAZOLE; OXIDOREDUCTASE; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; WW DOMAIN CONTAINING OXIDOREDUCTASE; CCND1 PROTEIN, HUMAN; PROTEIN C JUN; WWOX PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER PATIENT; CANCER TISSUE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CONTROLLED STUDY; FLOW CYTOMETRY; GENE OVEREXPRESSION; GENE REPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LNCAP CELL LINE; MALE; MITOSIS; MOUSE; NONHUMAN; PROSTATE CANCER; PROSTATE CANCER CELL LINE; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; TUMOR GROWTH; TUMOR XENOGRAFT; WESTERN BLOTTING; ANIMAL; CELL CYCLE CHECKPOINT; DISEASE COURSE; GENE SILENCING; METABOLISM; NUDE MOUSE; PATHOLOGY; PROSTATE TUMOR; TUMOR CELL LINE;

ANIMALS; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CYCLIN D1; DISEASE PROGRESSION; G1 PHASE; GENE SILENCING; HUMANS; MALE; MICE, NUDE; OXIDOREDUCTASES; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-JUN; TUMOR SUPPRESSOR PROTEINS;

EID: 84923169645     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/15384101.2014.977103     Document Type: Article

References (27)

1. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA: A cancer journal for clinicians 2014; 64: 9-29; PMID: 24399786
2. Powell IJ, Bollig-Fischer A. Minireview: The molecular and genomic basis for prostate cancer health disparities. Mol Endocrinol 2013; 27: 879-91; PMID: 23608645; http://dx.doi.org/10.1210/me.2013-1039
3. Alao JP, Gamble SC, Stavropoulou AV, Pomeranz KM, Lam EW, Coombes RC, Vigushin DM. The cyclin D1 proto-oncogene is sequestered in the cytoplasm of mammalian cancer cell lines. Mol Cancer 2006; 5: 7; PMID: 16503970; http://dx.doi.org/10.1186/1476-4598-5-7
4. Casimiro MC, Pestell RG. Cyclin d1 induces chromosomal instability. Oncotarget 2012; 3: 224-5; PMID: 22538871
5. Pluciennik E, Nowakowska M, Wujcicka WI, Sitkiewicz A, Kazanowska B, Zielinska E, Bednarek AK. Genetic alterations of WWOX in Wilms' tumor are involved in its carcinogenesis. Oncol Rep 2012; 28: 1417-22; PMID: 22842668; http://dx.doi.org/10.3892/or.2012.1940
6. Bednarek AK, Laflin KJ, Daniel RL, Liao Q, Hawkins KA, Aldaz CM. WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23.3-24.1, a region frequently affected in breast cancer. Cancer Res 2000; 60: 2140-5; PMID: 10786676
7. Chang NS, Doherty J, Ensign A, Lewis J, Heath J, Schultz L, Chen ST, Oppermann U. Molecular mechanisms underlying WOX1 activation during apoptotic and stress responses. Biochem Pharmacol 2003; 66: 1347-54; PMID: 14555208; http://dx.doi.org/10.1016/S0006-2952(03)00484-2
8. Lewandowska U, Zelazowski M, Seta K, Byczewska M, Pluciennik E, Bednarek AK. WWOX, the tumour suppressor gene affected in multiple cancers. J Physiol Pharmacol 2009; 60 Suppl 1: 47-56; PMID: 19609013
9. Qin HR, Iliopoulos D, Semba S, Fabbri M, Druck T, Volinia S, Croce CM, Morrison CD, Klein RD, Huebner K. A role for the WWOX gene in prostate cancer. Cancer Res 2006; 66: 6477-81; PMID: 16818616; http://dx.doi.org/10.1158/0008-5472.CAN-06-0956
10. Fabbri M, Iliopoulos D, Trapasso F, Aqeilan RI, Cimmino A, Zanesi N, Yendamuri S, Han SY, Amadori D, Huebner K, et al. WWOX gene restoration prevents lung cancer growth in vitro and in vivo. Proc Natl Acad Sci U S A 2005; 102: 15611-6; PMID: 16223882; http://dx.doi.org/10.1073/pnas.0505485102
11. Chang NS, Pratt N, Heath J, Schultz L, Sleve D, Carey GB, Zevotek N. Hyaluronidase induction of a WW domain-containing oxidoreductase that enhances tumor necrosis factor cytotoxicity. J Biol Chem 2001; 276: 3361-70; PMID: 11058590; http://dx.doi.org/10.1074/jbc.M007140200
12. Bednarek AK, Keck-Waggoner CL, Daniel RL, Laflin KJ, Bergsagel PL, Kiguchi K, Brenner AJ, Aldaz CM. WWOX, the FRA16D gene, behaves as a suppressor of tumor growth. Cancer Res 2001; 61: 8068-73; PMID: 11719429
13. Gourley C, Paige AJ, Taylor KJ, Ward C, Kuske B, Zhang J, Sun M, Janczar S, Harrison DJ, Muir M, et al. WWOX gene expression abolishes ovarian cancer tumorigenicity in vivo and decreases attachment to fibronectin via integrin alpha3. Cancer Res 2009; 69: 4835-42; PMID: 19458077; http://dx.doi.org/10.1158/0008-5472.CAN-08-2974
14. Gaudio E, Palamarchuk A, Palumbo T, Trapasso F, Pekarsky Y, Croce CM, Aqeilan RI. Physical association with WWOX suppresses c-Jun transcriptional activity. Cancer Res 2006; 66: 11585-9; PMID: 17178850; http://dx.doi.org/10.1158/0008-5472.CAN-06-3376
15. Fritz G, Kaina B. Activation of c-Jun N-terminal kinase 1 by UV irradiation is inhibited by wortmannin without affecting c-iun expression. Mol Cell Biol 1999; 19: 1768-74; PMID: 10022864
16. Ishii H, Vecchione A, Furukawa Y, Sutheesophon K, Han SY, Druck T, Kuroki T, Trapasso F, Nishimura M, Saito Y, et al. Expression of FRA16D/WWOX and FRA3B/FHIT genes in hematopoietic malignancies. Mol Cancer Res 2003; 1: 940-7; PMID: 14638866
17. Qin HR, Iliopoulos D, Nakamura T, Costinean S, Volinia S, Druck T, Sun J, Okumura H, Huebner K. Wwox suppresses prostate cancer cell growth through modulation of ErbB2-mediated androgen receptor signaling. Mol Cancer Res 2007; 5: 957-65; PMID: 17704139; http://dx.doi.org/10.1158/1541-7786.MCR-07-0211
18. Hu BS, Tan JW, Zhu GH, Wang DF, Zhou X, Sun ZQ. WWOX induces apoptosis and inhibits proliferation of human hepatoma cell line SMMC-7721. World J Gastroenterol 2012; 18: 3020-6; PMID: 22736928; http://dx.doi.org/10.3748/wjg.v18.i23.3020
19. Aqeilan RI, Palamarchuk A, Weigel RJ, Herrero JJ, Pekarsky Y, Croce CM. Physical and functional interactions between the Wwox tumor suppressor protein and the AP-2gamma transcription factor. Cancer Res 2004; 64: 8256-61; PMID: 15548692; http://dx.doi.org/10.1158/0008-5472.CAN-04-2055
20. Bouteille N, Driouch K, Hage PE, Sin S, Formstecher E, Camonis J, Lidereau R, Lallemand F. Inhibition of the Wnt/beta-catenin pathway by the WWOX tumor suppressor protein. Oncogene 2009; 28: 2569-80; PMID: 19465938; http://dx.doi.org/10.1038/onc. 2009.120
21. Kypta RM, Waxman J. Wnt/beta-catenin signalling in prostate cancer. Nat Rev Urol 2012; 9: 418-28; PMID: 22710668; http://dx.doi.org/10.1038/nrurol. 2012.116
22. Malumbres M, Barbacid M. Cell cycle, CDKs and cancer: A changing paradigm. Nat Rev Cancer 2009; 9: 153-66; PMID: 19238148; http://dx.doi.org/10.1038/nrc2602
23. Rico-Bautista E, Zhu W, Kitada S, Ganapathy S, Lau E, Krajewski S, Ramirez J, Bush JA, Yuan Z, Wolf DA. Small molecule-induced mitochondrial disruption directs prostate cancer inhibition via UPR signaling. Oncotarget 2013; 4: 1212-29; PMID: 23902736
24. Drobnjak M, Osman I, Scher HI, Fazzari M, Cordon-Cardo C. Overexpression of cyclin D1 is associated with metastatic prostate cancer to bone. Clin Cancer Res 2000; 6: 1891-5; PMID: 10815912
25. Noonan EJ, Place RF, Basak S, Pookot D, Li LC. miR-449a causes Rb-dependent cell cycle arrest and senescence in prostate cancer cells. Oncotarget 2010; 1: 349-58; PMID: 20948989
26. Zhang X, Zhao M, Huang AY, Fei Z, Zhang W, Wang XL. The effect of cyclin D expression on cell proliferation in human gliomas. J Clin Neurosci 2005; 12: 166-8; PMID: 15749420; http://dx.doi.org/10.1016/j.jocn.2004.03.036
27. Balk SP, Knudsen KE. AR, the cell cycle, and prostate cancer. Nucl Recept Signal 2008; 6: E001; PMID: 18301781; http://dx.doi.org/10.1621/nrs.06001